Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer
US6541468B1 · kind B1 · utility
24Cited by
18References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 25, 1999 |
| Grant date | Apr 1, 2003 |
| Priority date | — |
| Expiry date | Aug 25, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel indolocarbazole derivatives potentially useful for the treatment of dementias characterized by tau hyperphosphorylation [Alzheimer's disease (AD), frontal lobe degeneration (FLD), argyrophilic grains disease, subacute sclerotising panencephalitis (SSPE) as a late complication of viral infections in the CNS], and cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.